National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) / SBIR Phase II
Venture Capital
NIH institute funding small business innovation research in diabetes, digestive, and kidney disease commercialization.
Bethesda, United States · 1+ investments
Seed
Early Stage
Biotech
Healthcare
Medical Devices
- Headquarters
- Bethesda, United States
- Website
- niddk.nih.gov
- Total Investment
- 1
- Last Investment
- Dec 2023
- Geographic Focus
- United States
Investment Thesis
Fund small business R&D with commercial potential in diabetes, digestive diseases, kidney diseases, and related fields via NIH SBIR/STTR grant mechanisms.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) / SBIR Phase II is a Venture Capital firm based in Bethesda, United States. It has made 1 investment in Biotech and Healthcare.
Investment History
Sign up to view investment history
Create a free account to see deal history, investment amounts, and round details.